Literature DB >> 17644908

[Primary hyperoxaluria in children in central Tunisia].

Jalel Chemli1, Houda Abdennabi, Mejdi Zorgati, Sonia Abdelhak, Naoufel Nabli, Saoussen Abroug, Mohamed Tahar Sfar, Naceur Ben Dhia, Fethi Amri, Abdelaziz Harbi.   

Abstract

AIM: The goal of this work is to analyze clinical and therapeutics particularities of primary hyperoxaluria in children in Tunisian centre.
METHODS: We studied retrospectively 15 cases of primary hyperoxaluria enrolled during 9 years period (1994-2002).
RESULTS: It is about 2 boys and 13 girls (sex - ratio = 4.5) aged 2 month to 13 years (mean age: 4 years). Six patients presented the infantile form and nine the juvenile form of HP. At the moment of diagnosis, renal function was normal in one patient, moderately altered in another and severely altered in the other patients. All patients had nephrocalcinosis and 6 among them radio-opaque renal calculi associated. Diagnosis of HP was established in 11 cases by hyperoxaluria and/or important hyperoxalemia or on the data of the renal biopsy and biochemical analysis of renal calculi in 4 cases. The so-called "maghrebin" mutation (Ile244Thr) sought-after in 9 children, has cannot be identified that in 2 among them. Eight patients died of the continuations of their illness. The seven other patients again in life present a terminal renal insufficiency treated by haemodialysis. No patient could benefit from organ transplantation.
CONCLUSION: Primary hyperoxaluria is a very heterogeneous disease on the plan clinic that genetic. In Tunisia where it constitutes a frequent cause of end stage renal failure, prenatal diagnosis of this disease is of a big interest.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17644908

Source DB:  PubMed          Journal:  Tunis Med        ISSN: 0041-4131


  3 in total

Review 1.  Primary hyperoxaluria type 1 in developing countries: novel challenges in a new therapeutic era.

Authors:  Neveen A Soliman; Sameh Mabrouk
Journal:  Clin Kidney J       Date:  2022-05-17

2.  Selected AGXT gene mutations analysis provides a genetic diagnosis in 28% of Tunisian patients with primary hyperoxaluria.

Authors:  Ibtihel Benhaj Mbarek; Saoussen Abroug; Asma Omezzine; Dorsaf Zellama; Abdellatif Achour; Abdelaziz Harbi; Ali Bouslama
Journal:  BMC Nephrol       Date:  2011-05-25       Impact factor: 2.388

3.  Identification of compound heterozygous patients with primary hyperoxaluria type 1: clinical evaluations and in silico investigations.

Authors:  Houda Kanoun; Faiçal Jarraya; Bayen Maalej; Amina Lahiani; Hichem Mahfoudh; Fatma Makni; Jamil Hachicha; Faiza Fakhfakh
Journal:  BMC Nephrol       Date:  2017-10-02       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.